Sign in

    INmune Bio Inc (INMB)

    Q2 2025 Earnings Summary

    Reported on Jan 1, 1970 (After Market Close)
    Pre-Earnings Price$2.79Last close (Aug 7, 2025)
    Post-Earnings Price$2.42Open (Aug 8, 2025)
    Price Change
    $-0.37(-13.26%)
    MetricYoY ChangeReason

    Revenue Q1 2024

    Decreased from $38,000 in Q1 2023 to $14,000 in Q1 2024

    The decline of $24,000 is linked to the sale of MSCs to a third party in both periods; however, the documents do not offer specific details underlying the $24,000 drop in revenue.

    Revenue Q1 2025

    Increased from $14,000 in Q1 2024 to $50,000 in Q1 2025, an increase of $36,000

    The rise in revenue is primarily attributed to improved sales of MSCs to third parties compared to the previous period, reflecting a shift in sales volume and market traction.